Skip to content

Impact of Administration of Esmolol on Nociception Level-guided Control of Nociception.

Anesthesia | Nociceptive Pain | Opioid Use, Unspecified

This study aims to evaluate esmolol's perfusion impact during induction and maintenance of general anesthesia, using Nociception-Level-guided control of nociception, in adult patients undergoing laparoscopic and lower abdominal surgery, on intraoperative remifentanil consumption and postoperative pain in the Post-Anesthesia Care Unit.

null

Participation Requirements

  • Sex:

    ALL
  • Eligible Ages:

    18 to 65

Participation Criteria

Inclusion Criteria:

* Fully consented, American Society of Anesthesiologists Classification Score 1-3 patients from 18yo to 65yo
* Undergoing laparoscopic surgery associated with sub umbilical mini-laparotomy. Eligible surgeries will be hysterectomy (excluding vaginal approach) and left hemicolectomy, of duration time expected under 180 minutes, under general anesthesia
* No allergy to one of the medications used in this study

Exclusion Criteria:

Contraindication to the use of the study drug (esmolol) is an exclusion criterion :

* Hypotension
* Sinus bradycardia
* Sick sinus syndrome
* Second and third degree A-V block
* Pulmonary hypertension
* Right ventricular failure secondary to pulmonary hypertension
* Decompensated heart failure
* Cardiogenic shock
* Nontreated pheochromocytoma
* Known hypersensitivity to esmolol or any of the inactive ingredients of the product
* Allergy to esmolol or other beta blockers (cross-sensitivity is possible)
* Renal dysfunction
* Airway disease such as asthma or chronic obstructive pulmonary disease
* Thyrotoxicosis
* Myasthenia gravis
* Raynaud's disease or peripheral circulatory disorder

Other situations leading to exclusion :

* Severe mental impairment
* Chronic use of opioids, β-adrenergic receptors antagonists
* High risk of conversion to laparotomy according to the surgical team (\>25%)

Patients will automatically be excluded after recruitment if they withdraw their consent, or if laparoscopy is converted to laparotomy.

Study Location

Maisonneuve-Rosemont Hospital - CIUSSS de l'Est de l'Île de Montréal
Maisonneuve-Rosemont Hospital - CIUSSS de l'Est de l'Île de Montréal
Montréal-Est, Quebec
Canada

Contact Study Team

Primary Contact

Pascal Laferrière-Langois, MD FRQS

[email protected]
(819) 432-5847
Study Sponsored By
Ciusss de L'Est de l'Île de Montréal
Participants Required
More Information
Study ID: NCT06291363